Yakult Honsha Co.,Ltd.
2267
Pozycja w akcjach
#3393
Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the... Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the manufacturing and sale of a broad array of products, including food and beverages, cosmetics, and pharmaceuticals. The company's operations are segmented geographically for its Food and Beverages division, covering Japan, the Americas, Asia and Oceania, and Europe, alongside dedicated Pharmaceutical and "Others" segments. Its extensive food and beverage offerings feature popular items such as fermented milk beverages, various juices, and noodle products, which are distributed through both a home delivery service and traditional retail channels. In the pharmaceutical sector, Yakult Honsha provides specific medications like the antineoplastic drug Elplat, along with a suite of generic anti-cancer treatments, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Furthermore, the company maintains a presence in the cosmetics industry and is notably the owner of the professional baseball team, the Tokyo Yakult Swallows. Founded in 1935, Yakult Honsha Co.,Ltd. is headquartered in Tokyo, Japan.
Cena akcji
$17.80
Kapitalizacja rynkowa
$5.12B
Zmiana (1 dzień)
-0.02%
Zmiana (1 rok)
11.54%
Kraj
JP
Handel Yakult Honsha Co.,Ltd. (2267)
Kategoria
Consumer Defensive
Zyski dla Yakult Honsha Co.,Ltd. (2267)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Yakult Honsha Co.,Ltd., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Yakult Honsha Co.,Ltd. od 2026 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| Za mało danych dla podanych dat. | ||
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $17.23B | - |
US
|
|
| $13.73B | - |
US
|
|
| $2.78B | - |
US
|
|
| $3.25B | - |
CN
|
|
| $1.97B | - |
US
|
